Cytarabine Injection

Get a Price/Quote

Cytarabine Injection Specification

Salt Composition
Cytarabine

Dosage Form
Liquid Injection

Indication
Used in the treatment of certain cancers such as leukemia (including acute myeloid leukemia, acute lymphocytic leukemia, and chronic myelogenous leukemia) and lymphomas.

Feature
Sterile, pyrogen free, ready-to-use

Ingredients
Cytarabine and suitable excipients

Application
Intravenous or subcutaneous injection for oncology therapeutic use

Ph Level
Typically 7.0 - 8.5 (adjusted for injection preparation)

Temperature Needed For Fermentation
Not Applicable (Synthetic chemical preparation)

Physical Color/Texture
Clear, colorless to pale yellow liquid

Fermentation Smell
Odorless

Shelf Life
24 months from manufacture date

Cytarabine Injection Trade Information

Minimum Order Quantity
100 Piece

Delivery Time
30 Days

Sample Policy
Within a certain price range free samples are available

Main Export Market(s)
Australia, North America, Eastern Europe, Western Europe, Africa, Central America, Middle East, South America, Asia

Certifications
ISO, GMP, WHO

About Cytarabine Injection

Cytarabine Injection

Product Details:

Dose	100 mg/500mg/1gm
Usage	Clinical, Hospital, Personal
Packaging Size	1*1
Packaging Type	Vial

We Rewine Pharmaceutical are a leading Manufacturer and Exporter of Cytarabine injection in different strength and packing. Our manufacturing facility is certified with WHO-GMP.

Cytarine Injection is a medicine that is used for the treatment of Cancers of the blood, Cancer of the lymph glands and other conditions. Cytarine Injection contains Cytosine Arabinoside as an active ingredient. Cytarine Injection works by inhibiting the synthesis of DNA.

Composition :

Cytarabine 100mg
Cytarabine 500mg
Cytarabine 1gm

Product Type : Finished Product

Dose/Strength (ex. 1 mg or 1 ml): 100 mg/500mg/1gm
Type : Vial
Packing : 1*1
Usage: Clinical, Hospital

We manufacture and export our brand. We also offer private labelling, Contract manufacturing service.

Effective Treatment for Leukemia and Lymphoma

Cytarabine Injection is widely used as a key chemotherapeutic agent for managing leukemias such as acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML), as well as lymphoma. Its targeted mechanism helps inhibit abnormal cell growth, providing significant benefits in oncology settings.

Sterile, Ready-to-Use Formulation

Manufactured using strict aseptic techniques according to GMP guidelines, Cytarabine Injection is delivered as a sterile, pyrogen-free solution in glass vials. The ready-to-use liquid formulation ensures convenience and safety for both intravenous and subcutaneous administration by healthcare professionals.

Pharmaceutical Excellence and Compliance

This product meets international pharmacopeial standards, including USP, BP, and EP, ensuring consistent quality, efficacy, and safety. The formulations pH is carefully adjusted to a range of 7.08.5, supporting patient comfort and injection compatibility with standard IV fluids.

FAQs of Cytarabine Injection:

Q: How is Cytarabine Injection administered?

A: Cytarabine Injection is given either intravenously (IV) or subcutaneously (SC) as directed by a healthcare professional, depending on the prescribed treatment plan and clinical indication.

Q: What cancers is Cytarabine Injection commonly used to treat?

A: Cytarabine Injection is primarily indicated for the treatment of certain leukemias (acute myeloid leukemia, acute lymphocytic leukemia, chronic myelogenous leukemia) and lymphomas.

Q: When should Cytarabine Injection not be used?

A: This medicine should not be used in patients who are hypersensitive to Cytarabine or any component in the formulation. Any suspected allergy should be reported to the physician before use.

Q: What are the storage requirements for Cytarabine Injection?

A: Cytarabine Injection should be stored in a cool place, following the manufacturers label instructions, to maintain the products effectiveness throughout its 24-month shelf life.

Q: How does Cytarabine Injection benefit oncology patients?

A: Cytarabine works by inhibiting DNA synthesis in rapidly dividing cancer cells, which helps slow or stop the progression of leukemias and lymphomas, improving patient outcomes when used as part of a prescribed chemotherapy regimen.

Q: Is Cytarabine Injection ready to use upon receipt?

A: Yes, the injection is supplied as a sterile, pyrogen-free liquid in a clear, colorless to pale yellow solution, ready for immediate use by trained medical personnel.

Q: What standards and safety measures are followed in the manufacturing of Cytarabine Injection?

A: This injectable is produced using aseptic methods under Good Manufacturing Practice (GMP), and it meets stringent USP, BP, and EP standards for quality and safety.

Tell us about your requirement